ArticleScientific reports2025
Enhanced skin cancer classification using modified efficientNetV2L with adaptive early stopping mechanism.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Pixel Understanding to Semantic Insight: Intelligent Detection in Sensor-Driven Perception Systems.Sensors (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The accurate classification of skin cancer types is a critical task in medical diagnostics, requiring robust and reliable models to distinguish between various skin lesions. Despite advancements in deep learning, developing models that generalize well to unseen data remains a challenge. Current methodologies primarily utilize convolutional neural networks (CNNs) for image classification tasks, leveraging architectures such as ResNet, VGG, and Inception. These models have shown promise in improving classification accuracy for skin cancer detection. However, existing models often face limitations, including overfitting to the training data and difficulty in handling imbalanced datasets. This results in decreased performance on validation and test datasets, reducing their practical applicability in clinical settings. Additionally, these models may lack the fine-grained discrimination required to accurately classify a diverse range of skin lesion types. To address the limitations of traditional CNN-based approaches, we propose a novel model based on the EfficientNetV2L architecture, optimized for skin lesion classification. Our approach introduces adaptive early stopping and learning rate callbacks to enhance generalization and prevent overfitting. Trained on the ISIC dataset, the model achieved a high classification accuracy of 99.22%, demonstrating robustness across various lesion types. This work contributes a powerful, efficient, and clinically relevant solution to the field of automated skin cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.